2016: Anja van Arkens and Ulrikke Lynge Jensen assume full ownership of Billev Pharma. Over the last year the company has grown to more than 15 employees.
2015: The generational handover is entering a new phase. The Managing Director position is handed over to Anja van Arkens and Ulrikke Lynge Jensen. Peter de Mayo Billev is still associated with Billev Pharma as part time consultant. The Billev Pharma office in Slovenia separates from the Danish company and becomes an independent company, owned solely by Peter Billev and named Billev Pharma East. Billev Pharma in Denmark relocates from Tørslev to Hørsholm (Hoersholm) into a newly renovated, bright office located close to public transportation and the motorway. The office is located in BusinessPark Hørsholm, about 20 minutes’ drive north of central Copenhagen (25 km) and 35 minutes from Copenhagen airport (49 km).
2011: The process of a generational handover to Anja van Arkens and Ulrikke Lynge Jensen begins and they become joint owners of the company.
2007: Billev Pharma establishes an office in Ljubljana, Slovenia in order to help our clients obtaining authorisations at a higher speed in all parts of Europe.
2005 & 2006: Billev Pharma is awarded as a Gazelle Company by the Leading Danish Financial Newspaper Boersen. Gazelle is a term for a fast-growing business, which has at least doubled its revenue over a four-year period.
2004: Billev Pharma offers certified translations.
1978: Peter de Mayo Billev establishes Billev Pharma ApS providing services within Regulatory Affairs. Over the next years the company grows from a one-man company into a small size enterprise with a few employees.